Clinical Trials Directory

Trials / Completed

CompletedNCT02468492

Pilot Synovial Fluid Molecular/Stem Cell Response to PRP in Knee Osteoarthritis: Clinical & Imaging Outcome Correlation

Synovial Fluid Biomarker and Mesenchymal Stem Cell Response to PRP in Knee Osteoarthritis With Clinical and Imaging Outcome Correlation: Proof of Concept Study

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Hunter Holmes Mcguire Veteran Affairs Medical Center · Federal
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the affect that platelet rich plasma has on the molecular an cellular functioning of the knee joint.

Detailed description

In this study 18 subjects with mild to moderate symptomatic knee osteoarthritis will be recruited per an IRB approved protocol with explicit inclusion and exclusion criteria. Subjects who are enrolled and meet all criteria will be blinded and randomized (2:1) to receive Platelet Rich Plasma or normal saline "control". Prior to the intervention, a synovial fluid aspiration will occur. At follow up number one (approximately 10 days from baseline) a repeat aspiration will occur and a differential analysis of the molecular and biochemical effects will be undertaken; this data will serve as the primary outcome measures. This data will be correlated to clinical and imaging outcome measures which will be secondary outcome measures completed at baseline and intermittently throughout the study. The duration of the study is one year.

Conditions

Interventions

TypeNameDescription
BIOLOGICALPlatelet Rich PlasmaPlatelet rich plasma injection into knee versus placebo (saline) injection.
OTHERNormal SalinePlatelet rich plasma injection into knee versus placebo (saline) injection.

Timeline

Start date
2014-09-01
Primary completion
2015-11-01
Completion
2015-11-01
First posted
2015-06-10
Last updated
2017-08-16

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT02468492. Inclusion in this directory is not an endorsement.